Drug Index


Synonym :


Mechanism :

Gemfibrozil is a lipid regulating agent which decreases serum triglycerides and very low-density lipoprotein (VLDL) cholesterol and increases high density lipoprotein (HDL) cholesterol.

Indication :

• Hyperlipidemia

• Familial hypercholesterolemia

• Neonatal hyperbilirubinemia

Contraindications :

Known hypersensitivity to gemfibrozil, renal and hepatic dysfunction, and gall bladder disease are contraindications for its use.

Dosing :

Limited experience in children (Doses based on clinical trials).

Hyperlipidemia: 150-600 mg twice a day orally.

Neonatal hyperbilirubinemia:60 mg/kg 2 doses for 1 day PO.

Adverse Effect :

Nausea, anorexia, gastric pain, headache, pruritus, urticaria, myopathy, cholestatic jaundice, arrhythmias.

Interaction :

Warfarin: Enhanced effect.
HMG-COA reductase inhibitors: Increased risk of rhabdomyolysis.
Bile acid sequestrants: Elevation in liver enzymes.
Repaglinide and Simvastatin: Cannot be used with Gemfibrozil.

03/14/2020 07:02:16 Gemfibrozil
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0